Business and science: How risky is SynBio?

Available for over a year

For all the exciting developments in the synthetic biology industry, there are also concerns. People can edit genes in their garages these days, so who’s regulating this space? Plus - we’ll hear about the exciting new business models with biology at their core, including one of the first synbio businesses to trade as a public stock - Ginkgo Bioworks. Presenter: Gareth Mitchell Producer: Izzy Greenfield (Image: A petri dish in a lab. Credit: Getty Images)